Publication | Closed Access

Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study

Neuro-oncologyOpen-label Pilot StudyMedicineMelanomaPathologyBrafv600 Mutation-positive MelanomaCancer TreatmentOncologyRadiation OncologyMolecular OncologyFinal Results